Form 8.3 - Allergan plc

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

30 January 2020

  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,577,355

(1.089%)

1,890

(0.001%)

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

3,577,355

(1.089%)

1,890

(0.001%)

 
  1. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

  1. DEALINGS (Note 4)
  1. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

(USD)

Purchase

610

187.40

Purchase

55

187.45

Purchase

127

187.79

Sale

101

187.14

Sale

37

187.20

Sale

22

187.30

Sale

20

187.48

Sale

22

187.51

Sale

1,191

187.61

Purchase

102,109

187.61

Sale

33,950

187.61

Purchase

100

187.03

Purchase

196

187.05

Purchase

396

187.06

Purchase

365

187.07

Purchase

881

187.08

Purchase

2,137

187.09

Purchase

2,326

187.10

Purchase

4,286

187.11

Purchase

5,972

187.12

Purchase

10,367

187.13

Purchase

11,470

187.14

Purchase

12,833

187.15

Purchase

4,975

187.16

Purchase

4,197

187.17

Purchase

3,747

187.18

Purchase

1,942

187.19

Purchase

1,139

187.20

Purchase

852

187.21

Purchase

716

187.22

Purchase

800

187.23

Purchase

998

187.24

Purchase

1,151

187.25

Purchase

1,335

187.26

Purchase

750

187.27

Purchase

1,000

187.28

Purchase

700

187.29

Purchase

800

187.30

Purchase

700

187.31

Purchase

615

187.32

Purchase

400

187.33

Purchase

1,115

187.34

Purchase

1,000

187.35

Purchase

1,680

187.36

Purchase

400

187.37

Purchase

1,396

187.38

Purchase

1,100

187.39

Purchase

800

187.40

Purchase

800

187.41

Purchase

360

187.42

Purchase

404

187.43

Purchase

1,396

187.44

Purchase

600

187.45

Purchase

1,115

187.46

Purchase

614

187.47

Purchase

900

187.48

Purchase

974

187.49

Purchase

850

187.50

Purchase

601

187.51

Purchase

902

187.52

Purchase

414

187.53

Purchase

200

187.54

Purchase

100

187.55

Purchase

305

187.56

Purchase

200

187.57

Purchase

300

187.58

Purchase

400

187.59

Purchase

200

187.60

Purchase

34,952

187.61

Purchase

215

187.62

Purchase

1,229

187.63

Purchase

400

187.65

Purchase

100

187.66

Purchase

100

187.67

Purchase

111

187.68

Purchase

200

187.69

Purchase

100

187.71

Purchase

200

187.72

Purchase

204

187.73

Purchase

10

187.82

Purchase

100

187.85

Purchase

100

187.86

Purchase

100

187.87

Purchase

100

187.90

Purchase

100

187.93

Purchase

100

187.95

Purchase

100

187.99

Purchase

591

188.00

Purchase

100

188.02

Purchase

100

188.05

Purchase

300

188.06

Purchase

100

188.11

Purchase

100

188.12

Purchase

200

188.13

Purchase

100

188.14

Purchase

200

188.15

Purchase

100

188.16

Purchase

100

188.17

Purchase

100

188.18

Purchase

100

188.19

Purchase

100

188.21

Purchase

100

188.22

Purchase

100

188.23

Purchase

100

188.26

Purchase

100

188.32

Purchase

100

188.39

Purchase

100

188.41

Sale

5

187.43

Sale

556

187.57

Sale

100

187.58

Sale

102,109

187.61

Sale

10

188.00

  1. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasingor varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

  1. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

  1. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

31 January 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 691494
Time of Receipt (offset from UTC): 20200131T150123+0000

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.